Daniel is CEO and founder of Onvector, LLC. Daniel has more than 15 years of experience in the development of emerging growth technologies in cleantech and medical device fields. A graduate of Harvard University, Mr. Cho serves concurrently as managing director of Health Onvector Inc, a cardiovascular diagnostics company he founded to commercialize a diagnostic test for blood viscosity. At Health Onvector, he secured and strengthened IP, obtained regulatory compliance and reimbursement, and established a market for the diagnostic technology. From 2009 to 2010, he was Vice President of ProMetrics, a pharmaceutical consulting firm, where he led engagements with pharmaceutical companies and healthcare providers in the areas of cardiovascular and renal disease.
As a technology consultant to the cleantech industry, Daniel led the validation of an experimental water treatment technology for IMI Vision, the R&D arm of global beverage dispensing and cooling equipment manufacturer IMI Cornelius, and performed technology evaluation studies for Pentair Water Treatment, a division of Pentair. Previously, Mr. Cho was President and CEO of Vortex Aircon, a privately-held company providing energy-efficient technologies for the appliance industry, where he was responsible for securing $2 million in equity financing, establishing joint projects with GE Appliances and Samsung Electronics. He has co-authored over 15 peer-reviewed scientific articles and is the inventor of two pending patents.